Iterum Therapeutics plc

Iterum Therapeutics plc is a pharmaceutical company focused on developing and commercializing innovative anti-infectives to combat the global rise of multi-drug resistant infections. The company's primary focus is on developing oral and IV antibiotics to address the unmet needs of patients with infections caused by Gram-negative bacteria, including those resistant to commonly used antibiotics. Iterum Therapeutics aims to provide convenient and effective treatment options for patients in both hospital and community settings, contributing to improved patient outcomes and reduced healthcare costs. The company's research and development efforts are centered on addressing the growing challenge of antibiotic resistance and improving the management of infectious diseases. Through its commitment to innovation and patient-centric solutions, Iterum Therapeutics seeks to play a vital role in combating the global threat of antimicrobial resistance.